期刊文献+

丙泊酚、芬太尼注射液复合咪达唑仑静脉麻醉在90例妇产科门诊手术中的应用 被引量:5

Application of Propofol,Fengtanyl and Midazolam Intravenous Anesthesia in 90 Cases of Obstetrics and Gynecology Outpatient Surgery
下载PDF
导出
摘要 目的对进行妇产科门诊手术治疗的患者分组采取不同方法麻醉,研究丙泊酚+芬太尼+咪达唑仑在妇产科门诊手术中的应用价值及安全性。方法选择90例ASAⅠ-Ⅱ级要求在无痛下实施妇产科门诊手术的患者随机分为对照组和观察组,对照组采取小剂量咪达唑仑、芬太尼以及丙泊酚联合静脉麻醉,观察组采取芬太尼和丙泊酚静脉麻醉,并对所有患者进行麻醉后实施妇产科门诊手术的并发症情况分析。结果两组患者均未出现术中知晓。对照组相对于观察组来说,在患者出现血压降低以及呼吸抑制的方面少,而麻醉过程中丙泊酚用量也减少,差异具有统计学意义(P〈0.05)。结论丙泊酚、芬太尼复合小剂量咪达唑仑用于妇产科门诊手术中的麻醉较丙泊酚复合芬太尼更安全有效。 Objective To investigate the value and safety of propofol combined with fentanyl and midazolam,in obstetrics and gynecology outpatient operation. Methods Selected 90 cases of ASA Ⅰ-Ⅱ were randomly divided into control group and observation group to receive gynecological obstetrics and gynecology surgery. Control group were given midazolam,fentanyl,propofol and observation group used fentanyl combined with propofol. Observed the complication of two groups. Results Two groups of patients were not there intraoperative awareness. Significantly reducing the number of aspects of hypotension and respiratory depression in control group compared with observation group and the dosage of propofol was significantly reduced during anesthesia. This result was significant differences and exist statistically significant(P〈0.05). Conclusion Propofol combined with fentanyl,midazolam used in gynecology outpatient operation was more safe and effective comparedwith only fentanyl and propofol.
作者 姜锐奇
出处 《中国卫生标准管理》 2016年第1期174-175,共2页 China Health Standard Management
关键词 咪达唑仑 丙泊酚 芬太尼 静脉麻醉 妇产科门诊手术 安全性 Midazolam Fentanyl Propofol Intravenous anesthesia Obstetrics and gynecology outpatient surgery Safety
  • 相关文献

参考文献7

二级参考文献17

  • 1Ben-Shlomo I, Finger J, Bar-Av E, et al. Propofol and fentanyl act additively for induction of anaesthesia. Anaesthsia, 1993,48:111-113. 被引量:1
  • 2Vuyk J, Lira T, Engbers FH, et al. Pharmacodynamics of alfentanil as a supplement to propofol or nitrous oxide for lower abdominal surgery in female patients. Anaesthesiology, 1993,78 : 1036-1045. 被引量:1
  • 3Vree TB, Baars AM, de Grood PM. High performance liquid chromatographic determination and preliminary pharmacokinetics of propofol and its metabolites in human plasma and urine. J Chromatogr, 1987,417 : 458-464. 被引量:1
  • 4Kirkpatrick T, Cockshott ID, Douglas EJ, et al. Pharmacokineties of propofol (Diprivan)in elderly patients.British J Anaesthsia, 1988,60 : 146-150. 被引量:1
  • 5Vuyk J. Pharmacokinetic and pharmacodynamic interactions between opioids and propofol. J Clin Anesth, 1997,9(Suppl 6) :23-26. 被引量:1
  • 6Murat I, Billard V, Vernois J, et al. Pharmacokinetics of propofol after a single dose in children aged 1-3 years with minor burns. Comparison of three data analysis approaches. Anaesthesiology, 1996,84 : 526-532. 被引量:1
  • 7Schutthr J, Ihmsen H. Population pharmacokinetics of propofol., a multicenter study. Anaesthesiology, 2000,92 :727-738. 被引量:1
  • 8Schnider TW, Minto CF, Sharer SL, et al. The influence of age on propofol pharmacodynamics. Anaesthesiology,1999,90 : 1502-1516. 被引量:1
  • 9Clotz MA,Nahata MC.Clinical uses of fentanyl,sufentanil and alfentanil[J].Clin Pharm,1996,10:581. 被引量:1
  • 10Mccollum JSC,Dundee JW.Comparision of the inducrion characteristics of four intravenous anesthetic agents[J].Anaesthesia,1994,41:995. 被引量:1

共引文献386

同被引文献29

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部